Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions		3 Months Ended		6 Months Ended
		Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Net Sales		$ 13,834	$ 11,952	$ 27,064	$ 22,655
Cost of sales		10,764	9,275	20,961	17,226
Research and development expenses		405	399	821	760
Selling, general and administrative expenses		855	787	1,722	1,529
Amortization of intangibles		157	122	312	225
Restructuring charges (credits)		(12)	454	(13)	452
Equity in earnings of nonconsolidated affiliates		54	82	250	121
Sundry income (expense) - net		299	2,550	(171)	1,309
Interest income		22	18	47	38
Interest expense and amortization of debt discount		226	208	445	409
Income Before Income Taxes		1,814	3,357	2,942	3,522
Provision for income taxes		455	130	668	20
Net Income		1,359	3,227	2,274	3,502
Net income attributable to noncontrolling interests		38	19	65	40
Net Income Attributable to The Dow Chemical Company		1,321	3,208	2,209	3,462
Preferred stock dividends	[1]	0	85	0	170
Net Income Available for The Dow Chemical Company Common Stockholders		$ 1,321	$ 3,123	$ 2,209	$ 3,292
Per Common Share Data:
Earnings per common share - basic		$ 1.08	$ 2.79	$ 1.82	$ 2.96
Earnings per common share - diluted		1.07	2.61	1.79	2.83
Dividends declared per share of common stock		$ 0.46	$ 0.46	$ 0.92	$ 0.92
Weighted-average common shares outstanding - basic		1,211.8	1,111.1	1,207.2	1,107.0
Weighted-average common shares outstanding - diluted		1,229.0	1,222.8	1,225.5	1,218.5
Depreciation		$ 534	$ 511	$ 1,112	$ 967
Capital Expenditures		$ 795	$ 997	$ 1,549	$ 1,817

[1] On December 30, 2016, the Company converted its outstanding shares of Cumulative Convertible Perpetual Preferred Stock, Series A ("Preferred Stock") into shares of the Company's common stock. As a result of this conversion, no shares of Preferred Stock are issued or outstanding.